Viewing StudyNCT00139620



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00139620
Status: COMPLETED
Last Update Posted: 2018-02-08
First Post: 2005-08-25

Brief Title: A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors With Adequate and Moderately Impaired Hepatic Function
Sponsor:
Organization: Astellas Pharma Inc